An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NTP Developmental and Reproductive Toxicity Technical Report on the Modified One-Generation Study of 2-Hydroxy-4-methoxybenzophenone (CASRN 131-57-7) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats with Prenatal and Reproductive Performance Assessments in F1 Offspring: DART Report 05 [Internet].
National Toxicology Program.
Research Triangle Park (NC): National Toxicology Program; 2022 Jun.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 91.)
Oral Contraceptives & Breast Cancer.
Institute of Medicine (US) Committee on the Relationship Between Oral Contraceptives and Breast Cancer.
Washington (DC): National Academies Press (US); 1991.
NTP Research Report on the Consortium Linking Academic and Regulatory Insights on Bisphenol A Toxicity (CLARITY-BPA): A Compendium of Published Findings: Research Report 18 [Internet].
CLARITY-BPA Research Program.
Research Triangle Park (NC): National Toxicology Program; 2021 Oct.
Drugs and Lactation Database (LactMed®) [Internet].
Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
Evidence reviews for management of heavy menstrual bleeding: Heavy menstrual bleeding (update): Evidence review B.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 88.)
Hormonal Contraception and Post-menopausal Hormonal Therapy.
Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 72.)
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Pharmaceuticals.
Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100A.)
Medical Eligibility Criteria for Contraceptive Use. 5th edition.
Geneva: World Health Organization; 2015.
Selected Practice Recommendations for Contraceptive Use. 3rd edition.
Geneva: World Health Organization; 2016.
Scientific Studies Supporting Development of Transcriptomic Points of Departure for EPA Transcriptomic Assessment Products (ETAPs).
Auerbach S, Casey W, Chang D, et al.
Washington (DC): U.S. Environmental Protection Agency; 2024 Mar.
NTP Research Report on the CLARITY-BPA Core Study: A Perinatal and Chronic Extended-Dose-Range Study of Bisphenol A in Rats: Research Report 9 [Internet].
Research Triangle Park (NC): National Toxicology Program; 2018 Sep.
Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Therapeutic area: Acne vulgaris: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Feb.
Medical Technology Assessment Directory: A Pilot Reference To Organizations, Assessments, and Information Resources.
Institute of Medicine (US) Council on Health Care Technology; Goodman C, editor.
Washington (DC): National Academies Press (US); 1988.
Therapeutics Letter.
Perry T, editor.
Vancouver (BC): Therapeutics Initiative; 1994-.
Drug Treatments for the Prevention of Migraine Headache.
Gray RN, Goslin RE, McCrory DC, et al.
Rockville (MD): Agency for Health Care Policy and Research (US); 1999 Feb. (Technical Reviews, No. 2.3.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on